Report overview
This report contains market size and forecasts of Biosimilars/follow-on-biologics in Global, including the following market information:
Global Biosimilars/follow-on-biologics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biosimilars/follow-on-biologics market was valued at 9560.2 million in 2021 and is projected to reach US$ 11700 million by 2028, at a CAGR of 2.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Human growth hormone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biosimilars/follow-on-biologics include Novartis (Sandoz), Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion Biocon, Hospira, Merck Serono (Merck), Biogen idec and Genentech (Roche). etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biosimilars/follow-on-biologics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilars/follow-on-biologics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biosimilars/follow-on-biologics Market Segment Percentages, by Type, 2021 (%)
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Global Biosimilars/follow-on-biologics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biosimilars/follow-on-biologics Market Segment Percentages, by Application, 2021 (%)
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Global Biosimilars/follow-on-biologics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biosimilars/follow-on-biologics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilars/follow-on-biologics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biosimilars/follow-on-biologics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
